Fed. Circ. Lifts Sales Ban On Generic Lovenox
The Federal Circuit on Friday overturned an injunction blocking Amphastar Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. from selling a generic version of the blood thinner Lovenox after finding that the companies...To view the full article, register now.
Already a subscriber? Click here to view full article